Integrative annotation of variants from 1092 humans: application to cancer genomics
about
Sequencing pools of individuals — mining genome-wide polymorphism data without big fundingRecombination affects accumulation of damaging and disease-associated mutations in human populationsImproved exome prioritization of disease genes through cross-species phenotype comparisonPractical aspects of NGS-based pathways analysis for personalized cancer science and medicineQuantitative Trait Loci Identify Functional Noncoding Variation in CancerThe search for cis-regulatory driver mutations in cancer genomesTranscriptional enhancers: functional insights and role in human diseaseDevelopments in our understanding of the genetic basis of birth defectsThe Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and OpportunitiesImpact of allele-specific peptides in proteome quantificationTranscriptional Dynamics at Brain Enhancers: from Functional Specialization to NeurodegenerationThe genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discoveryMechanisms of mutational robustness in transcriptional regulationORegAnno 3.0: a community-driven resource for curated regulatory annotationEvolutionary constraint and disease associations of post-translational modification sites in human genomesThe population genomics of rhesus macaques (Macaca mulatta) based on whole-genome sequencesIndividualized medicine from prewomb to tombCis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomas.Intensification: A Resource for Amplifying Population-Genetic Signals with Protein Repeats.A statistical framework to predict functional non-coding regions in the human genome through integrated analysis of annotation data.Global inference of disease-causing single nucleotide variants from exome sequencing dataDark matter RNA illuminates the puzzle of genome-wide association studies.Whole-genome analysis of papillary kidney cancer finds significant noncoding alterationsAncient genes establish stress-induced mutation as a hallmark of cancerLaying a solid foundation for Manhattan--'setting the functional basis for the post-GWAS era'.Applications of the 1000 Genomes Project resourcesComprehensive whole genome sequence analyses yields novel genetic and structural insights for Intellectual Disability.Genome annotation for clinical genomic diagnostics: strengths and weaknessesPrioritization of neurodevelopmental disease genes by discovery of new mutations.Analysis of stop-gain and frameshift variants in human innate immunity genes.Landscape of somatic mutations in 560 breast cancer whole-genome sequences.Expanding the computational toolbox for mining cancer genomes.Missing heritability of common diseases and treatments outside the protein-coding exome.Human genomic regions with exceptionally high levels of population differentiation identified from 911 whole-genome sequences.FunSeq2: a framework for prioritizing noncoding regulatory variants in cancerWalking the interactome for candidate prioritization in exome sequencing studies of Mendelian diseases.A method for calculating probabilities of fitness consequences for point mutations across the human genomeEnhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell lymphoma.SuRFing the genomics wave: an R package for prioritising SNPs by functionalityOncoCis: annotation of cis-regulatory mutations in cancer.
P2860
Q22121997-664B35DD-021D-48F9-BFA2-1762A5EEC3D1Q22122064-7F0F13FF-D802-4EEF-810A-E491776A6AACQ23815226-DC85E2AA-88A1-4E21-9C52-143E14F6663BQ26748603-452721EC-A200-4381-B727-881C75C842F0Q26764745-54D4B89E-7DF7-45BC-9399-95C34271B18DQ26781886-91CE5CF1-5FD9-4B11-AADD-581B06B7BF80Q26782507-26298A66-9E7C-4037-8115-98085BC10882Q26827284-D66E51DA-6721-427F-A2B2-E1F02758AD56Q27014740-C89A90D4-8F79-422C-96B3-747D1E195A8EQ27016149-067C9AD0-3F28-4912-AFD4-96D32BB8F090Q28067751-B182D555-BA3D-4D2E-8587-BB2A8983387CQ28077234-F424D078-D111-48CA-8D10-B9E231F3EE91Q28082759-3726596A-7A89-4FB5-8262-AF47AE936FB3Q28269966-2D427A27-3985-4C21-9E40-642597EC78D6Q28543059-5CFE09CC-23D9-4E60-A7D7-66E885627721Q28591103-D15910F1-B826-46D1-8AE6-490854A811C9Q29525070-C5245EC0-268F-42BF-B718-F2A9147A3F20Q30374056-E60E1684-65A9-4CA4-9B2A-7EBC505A9599Q30396267-1FB73F7D-AD3F-4403-8F7B-8A3A25961527Q30959484-EC5CBEFB-8A82-41DB-B4E9-172D4E83CC37Q31159221-6DC8D268-88CE-49BE-A743-FDE552C24F99Q33358608-A8B339EC-96F3-44B1-98EA-AAFCFB56957DQ33563168-29C84425-D027-4488-A808-D3243BA18648Q33602374-12C426D1-A637-4593-823A-D839F7F70AEAQ33631309-B0ECADC4-D54E-4C14-A53F-E837B8EDC8B9Q33711909-3DE8E3ED-C4FA-4A7B-A9FA-4CF126F4359EQ33721903-08EC4501-FCC0-4FD9-A2B0-1E542F77AA97Q33737782-CE3FF885-2464-471F-AF16-FE93257F2759Q33830995-AD0C142D-44F7-417A-ADDF-4B2A1597A964Q33946297-FDFD45E8-FE66-4B22-89A5-A2E61B926B11Q34046731-F4B5B1AE-8E71-41F5-83F2-37D0834F40A8Q34207474-A1E79811-9FEF-4CF4-ABEB-41E19FA9D6E5Q34212558-0748A9E7-6E3A-4041-8D9B-5CBD1C1A5BD4Q34342301-2F8AD0BC-16C5-41F6-825E-13E28C1726CAQ34375331-CF2DCAC5-9573-4A7A-A3D8-CDC61C5BDC01Q34456701-0B67B14D-A5B6-4EF6-9EB5-D110741C755EQ34458674-13CA468E-DBC5-4457-80DA-B35083632AE9Q34458974-2074BC16-8BA0-4123-969D-17C311BB8F68Q34474372-5A46F746-1CD8-4DEE-A4C3-FDD6764C103AQ34474391-F6B36A6E-7154-4735-B8FC-F99459886425
P2860
Integrative annotation of variants from 1092 humans: application to cancer genomics
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Integrative annotation of variants from 1092 humans: application to cancer genomics
@ast
Integrative annotation of variants from 1092 humans: application to cancer genomics
@en
Integrative annotation of variants from 1092 humans: application to cancer genomics
@en-gb
Integrative annotation of variants from 1092 humans: application to cancer genomics
@nl
type
label
Integrative annotation of variants from 1092 humans: application to cancer genomics
@ast
Integrative annotation of variants from 1092 humans: application to cancer genomics
@en
Integrative annotation of variants from 1092 humans: application to cancer genomics
@en-gb
Integrative annotation of variants from 1092 humans: application to cancer genomics
@nl
prefLabel
Integrative annotation of variants from 1092 humans: application to cancer genomics
@ast
Integrative annotation of variants from 1092 humans: application to cancer genomics
@en
Integrative annotation of variants from 1092 humans: application to cancer genomics
@en-gb
Integrative annotation of variants from 1092 humans: application to cancer genomics
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Integrative annotation of variants from 1092 humans: application to cancer genomics
@en
P2093
Arif Harmanci
Daniel Challis
Daniel G MacArthur
Declan Clarke
Dimple Chakravarty
Ekta Khurana
Emmanouil T Dermitzakis
Erik Garrison
Gabor Marth
P2860
P304
P3181
P356
10.1126/SCIENCE.1235587
P407
P50
P577
2013-10-04T00:00:00Z